ArticleCancer research and treatment2026

Alteration of HER2 Status Following Neoadjuvant Chemotherapy in Breast Cancer: A Clinicopathological Analysis Focusing on HER2-Low Status.

Hyun-Jung Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.